close
close
migores1

UBS Group Begins Coverage of Xylem (NYSE:XYL)

Equities researchers at UBS Group started coverage on the stock from Xylem (NYSE:XYL – Get a Free Report) in a research report issued on Tuesday, MarketBeat.com reports. The brokerage set a “buy” rating and a $165.00 target price on the industrial products company’s stock. UBS Group’s price target suggests a potential upside of 29.41% from the company’s current price.

A number of other equities research analysts also recently weighed in on XYL. Royal Bank of Canada raised their price objective on Xylem from $160.00 to $163.00 and gave the company an “outperform” rating in a report on Wednesday, July 31st. Robert W. Baird upped their target price on Xylem from $155.00 to $170.00 and gave the company an “outperform” rating in a research report on Wednesday, July 31st. Stifel Nicolaus raised their price objective on Xylem from $170.00 to $172.00 and gave the company a “buy” rating in a report on Wednesday, July 31st. Oppenheimer upped their target price on shares of Xylem from $147.00 to $152.00 and gave the stock an “outperform” rating in a report on Friday, May 31st. Finally, TD Cowen raised their target price on shares of Xylem from $135.00 to $138.00 and gave the company a “buy” rating in a report on Thursday, June 6th. Five research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. The company presently has a consensus rating of “Moderate Buy” and an average target price of $147.54, according to MarketBeat.com.

Read the latest stock report on XYL

Xylem Stock Performance

Want more great investment ideas?

Shares of NYSE XYL opened at $127.50 on Tuesday. Xylem has a one year low of $87.59 and a one year high of $146.08. The company has a current ratio of 1.85, a quick ratio of 1.33, and a debt-to-equity ratio of 0.19. The company has a fifty day simple moving average of $135.96 and a 200 day simple moving average of $131.98. The firm has a market cap of $30.97 billion, a price-to-earnings ratio of 45.37, a PEG ratio of 2.27 and a beta of 1.04.

Xylem (NYSE:XYL – Get Your Free Report ) last announced its quarterly earnings data on Tuesday, July 30th. The industrial products company reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.05 by $0.04. Xylem had a net margin of 9.11% and a return on equity of 9.48%. The company had revenue of $2.17 billion during the quarter, compared to analysts’ expectations of $2.14 billion. In the same quarter last year, the company posted EPS of $0.98. The company’s revenue increased by 26.0% year-over-year. sell-side analysts expect that Xylem will post 4.25 EPS for the current year.

Indoor activity

In other Xylem news, SVP Rodney Aulick sold 21,800 shares of Xylem stock in a transaction dated Wednesday, June 5th. The shares were sold at an average price of $139.01, for a total value of $3,030,418.00. Following the sale, the senior vice president now directly owns 76,287 shares in the company, valued at approximately $10,604,655.87. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed via this link. In related news, CAO Geri-Michelle Mcshane sold 2,278 shares of the business’s stock in a transaction on Monday, June 10th. The shares were sold at an average price of $138.63, for a total transaction of $315,799.14. Following the transaction, the chief accounting officer now directly owns 3,536 shares in the company, valued at $490,195.68. The sale was disclosed in a filing with the SEC, which is available at this link. Also, SVP Rodney Aulick sold 21,800 shares of the stock in a transaction dated Wednesday, June 5th. The shares were sold at an average price of $139.01, for a total transaction of $3,030,418.00. Following the completion of the sale, the senior vice president now owns 76,287 shares of the company’s stock, valued at approximately $10,604,655.87. The disclosure for this sale can be found here. 0.27% of shares are owned by corporate insiders.

Institutional investors are weighing in on Xylem

Several hedge funds have recently bought and sold shares of XYL. International Assets Investment Management LLC boosted its position in Xylem by 10,296.7% in the fourth quarter. International Assets Investment Management LLC now owns 63,004 shares of the industrial products company’s stock worth $7,205,000 after buying an additional 62,398 shares during the period. Cerity Partners LLC raised its position in shares of Xylem by 10.5% in the fourth quarter. Cerity Partners LLC now owns 47,621 shares of the industrial products company’s stock worth $5,446,000 after buying an additional 4,537 shares in the last quarter. Perigon Wealth Management LLC bought a new position in shares of Xylem during the fourth quarter valued at approximately $230,000. Simplicity Solutions LLC raised its holdings in Xylem by 3.9% during the 4th quarter. Simplicity Solutions LLC now owns 3,952 shares of the industrial products company’s stock worth $452,000 after acquiring an additional 150 shares in the last quarter. Finally, Louisiana State Employees Retirement System bought a new stake in Xylem in the 4th quarter valued at $1,670,000. 87.96% of the shares are currently owned by institutional investors and hedge funds.

About Xylem

(Get a free report)

Xylem Inc, together with its subsidiaries, is engaged in the design, manufacture and service of engineering products and solutions worldwide. It operates through four segments: water infrastructure, applied water, measurement and control solutions, and integrated solutions and services. The Water Infrastructure segment offers products including pumps for water, stormwater and wastewater; controls and systems; filtration, disinfection and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco and Xylem Vue brands.

Featured stories

Analyst Recommendations for Xylem (NYSE:XYL)

Get news and reviews for Xylem Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Xylem and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Articles

Back to top button